| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | BIOTECNOLOGÍA | 278,070000 | 138.045,610000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | BIOTECNOLOGÍA | 3.025,930000 | 38.812,940000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 7.112,895502 | 27.393,960000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 2.909,610000 | 39.959,750000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 750,641355 | 44.444,530000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 450,220000 | 19.940,300000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 342,765521 | 97.721,790000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 294,640000 | 6.144,630000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.605,968873 | 123.797,390000 | · | 23/04/2026 |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.459,130000 | 289.422,830000 | · | 23/04/2026 |
